The largest database of trusted experimental protocols

Celltitre glo luminescent viability kit

Manufactured by Promega
Sourced in United States

The CellTiter-Glo luminescent viability kit is a cell-based assay that quantifies ATP, which indicates the presence of metabolically active cells. The kit uses a luminescent substrate that produces light in the presence of ATP, enabling the measurement of cell viability and proliferation.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using celltitre glo luminescent viability kit

1

Cell Viability and Caspase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability and caspase activity was determined using the CellTitre-Glo luminescent viability kit and caspase Glo assays (Promega, Madison, USA) as described in the manufacturer’s instructions.
+ Open protocol
+ Expand
2

Determining Synergistic Drug Combinations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability and caspase activity was determined using the CellTitre-Glo® luminescent viability kit and caspase Glo® assays (Promega, Madison, USA) as described in the manufacturer's instructions. Calcusyn Software Version 2.1 (Cambridge Computing Imaging Ltd, Cambridge, UK) was used to calculate the combination index (CI) using the percentage of cells affected. The Chou-Talalay method [62 (link)] is employed by Calcusyn for calculating the CI. The software uses a method based on the median effect equation (MEE) derived from the mass action law and correlates dose and effect to produce the CI value; anything less than one showing a level of synergy (closer the number to 0 shows a greater degree of synergy) or a number greater than 1 showing antagonism between the agents. In this case we used the percentage of non-viable cells after treatment (as determined by the CellTitre-Glo® assay described above) as the fractional affect. This data is input into the software along with the dose of all agents used in the combination treatment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!